beta3 adrenergic agonists

The present invention relates to a beta3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful, e.g., for treating Type 2 diabetes and/or obesity

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SPINAZZE PATRICK GIANPIETRO, KARANJAWALA RUSHAD ERUCH, TRANKLE WILLIAM GEORGE, BASTIAN JOLIE ANNE, ROCCO VINCENT PATRICK, SALL DANIEL JON, HE JOHN XIAOQIANG, JESUDASON CYNTHIA DARSHINI, WERNER JOHN ARNOLD, EVERS BRITTA, STEVENS FREDDIE CRAIG, SCHOTTEN THEO, REUHTER GERD, FINLEY DON RICHARD, RATZ ANDREW MICHAEL
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a beta3 adrenergic receptor agonist of formula (I); or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful, e.g., for treating Type 2 diabetes and/or obesity